<qa>  What is the opinion of the physician investigator that the patient might benefit from continuing treatment with deTo evaluate the safety and tolerability of extended treatment with depsipeptide in patients who have at least demonstrated stable disease on prior Gloucester-sponsored depsipeptide clinical trials, and in the opinion of their physician investigator might benefit from continued treatment with depsipeptide 